Dr Paul Kemp, Founder and Chief Scientific Officer of UK-based company Intercytex will be speaking at our ‘Future Advances in Regenerative Medicine’meeting on June 13^{th .}. He will be discussing his experience of building and growing a viable Regenerative Medicine company and how strategies will be adapted to the changing scientific and regulatory environment in the future.  

The agenda of this meeting features exciting talks from many other stem cell researchers:

Introduction by the Chair: Dr Stephen Minger, Kings College, UK- Director of the Stem Cell Biology Laboratory and a Senior Lecturer in the Wolfson Centre for Age Related Diseases at King's College London.

Updates on Regenerative Medicine: Nanobiomaterials and Stem Cells
Professor Nureddin Ashammakhi, Keele University, UK

Limbal epithelial stem cell therapy for the treatment of blinding ocular surface disease.
Dr Julie T Daniels, Director, Moorfields Eye Hospital Cells for Sight Tissue Bank, UK

Stem Cell Transplantation Supports the Repair of Injured Olfactory Neuroepithelium after Permanent Damage

Professor Roberto P. Revoltella, University of Pisa, Italy

Differentiation of embryonic stem cells towards germ cells
Dr Lyle Armstrong, Centre For Stem Cell Biology & Developmental Genetics International Centre For Life, UK

Interaction of Grafted Neural Precursor Cells with Purkinje Cells in a SCA1 Mouse Model

Satyan Chintawar, Laboratory of Experimental Neurology, ULB, Brussels, Belgium

Neural transplantation for Parkinson's and Huntington's disease: stem cells and beyond
Dr Rike Zietlow, Cardiff University, UK

The Role of the UK Stem Cell Bank in Cellular Therapy

Dr Charles Hunt, UK Stem Cell Bank, National Institute for Biological Standards and Control

To book a place please visit http://www.regonline.co.uk/adultstem08